Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) price on Friday, May 23, rose 1.12% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $24.47.
A look at the stock’s price movement, the close in the last trading session was $24.20. The PE ratio in trailing twelve months stood at 8.88. Turning to its 52-week performance, $53.96 and $22.64 were the 52-week high and 52-week low respectively. Overall, AMPH moved 1.66% over the past month.
Amphastar Pharmaceuticals Inc’s market cap currently stands at around $1.15 billion, with investors looking forward to this quarter’s earnings report slated for in June.
Analysts have a consensus estimate of 173.41M for the company’s revenue for the quarter, with a low and high estimate of 161M and 182M respectively. The average forecast suggests down to a -4.92% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 722.25M, representing a -1.33% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that AMPH is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend AMPH as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
AMPH’s current price about 0.44% and -3.61% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 48.56, while 7-day volatility ratio is 2.29% and 2.36% in the 30-day chart. Further, Amphastar Pharmaceuticals Inc (AMPH) has a beta value of 0.75, and an average true range (ATR) of 0.90. Analysts have given the company’s stock an average 52-week price target of $32, forecast between a low of $32 and high of $32. Looking at the price targets, the low is -30.77% off current price level while to achieve the yearly target high, price needs to move -30.77%. Nonetheless, investors will most likely welcome a -30.77% jump to $32 which is the analysts’ median price.
If we refocus on Amphastar Pharmaceuticals Inc (NASDAQ:AMPH), historical trading data shows that trading volumes averaged 632.81K over the past 3 months. The company’s latest data on shares outstanding shows there are 47.67 million shares.
The 26.16% of Amphastar Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 72.35% of the company’s shares. Current price change has pushed the stock -34.10% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the AMPH stock continues to rise going into the next quarter.
